These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7874800)

  • 1. Background correction in estimating initial renal uptake. Comparison between Tc-99m MAG3 and Tc-99m DTPA.
    Inoue Y; Machida K; Honda N; Takahashi T; Mamiya T
    Clin Nucl Med; 1994 Dec; 19(12):1049-54. PubMed ID: 7874800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
    Mustafa S; Elgazzar AH
    J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accuracy of quantitative parameters in (99m) Tc-MAG3 dynamic renography: a national audit based on virtual image data.
    Brolin G; Edenbrandt L; Granerus G; Olsson A; Afzelius D; Gustafsson A; Jonsson C; Hagerman J; Johansson L; Riklund K; Ljungberg M
    Clin Physiol Funct Imaging; 2016 Mar; 36(2):146-54. PubMed ID: 25348641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hydration status in normal subjects: fractional analysis of parameters of Tc-99m DTPA and Tc-99m MAG3 renography.
    Jung HS; Chung YA; Kim EN; Kim SH; Lee SY; Sohn HS; Park YH; Chung SK
    Ann Nucl Med; 2005 Feb; 19(1):1-7. PubMed ID: 15770966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of renal function from 99mTc-MAG3 renography without blood sampling.
    Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Asai S; Ohtomo K
    J Nucl Med; 1999 May; 40(5):793-8. PubMed ID: 10319752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note.
    Fraile M; Castell J; Buxeda M; Cuartero A; Cantarell C; Domenech-Torné FM
    Eur J Nucl Med; 1989; 15(12):776-9. PubMed ID: 2533892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Tc-99m MAG3 and Tc-99m DTPA scintigraphy in neonates.
    Taylor A; Clark S; Ball T
    Clin Nucl Med; 1994 Jul; 19(7):575-80. PubMed ID: 7924094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the normal range of furosemide half-clearance times when using Tc-99m MAG3.
    Rossleigh MA; Thomas MY; Moase AL
    Clin Nucl Med; 1994 Oct; 19(10):880-2. PubMed ID: 7805322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
    Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
    Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation.
    O'Malley JP; Ziessman HA; Chantarapitak N
    Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of administered activity on precision in the assessment of renal function using gamma camera renography.
    Moonen M; Jacobsson L
    Nucl Med Commun; 1997 Apr; 18(4):346-51. PubMed ID: 9170620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of methods for determination of glomerular filtration rate: low and high-dose Tc-99m-DTPA renography, predicted creatinine clearance method, and plasma sample method.
    Assadi M; Eftekhari M; Hozhabrosadati M; Saghari M; Ebrahimi A; Nabipour I; Abbasi MZ; Moshtaghi D; Abbaszadeh M; Assadi S
    Int Urol Nephrol; 2008; 40(4):1059-65. PubMed ID: 18690545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of renal function with 99mTc-MAG3 using semiautomated regions of interest.
    Inoue Y; Yoshikawa K; Yoshioka N; Watanabe T; Saegusa S; Kaneko Y; Yokoyama I; Ohtomo K
    J Nucl Med; 2000 Dec; 41(12):1947-54. PubMed ID: 11138677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential renal function estimation by dynamic renal scintigraphy: influence of background definition and radiopharmaceutical.
    Caglar M; Gedik GK; Karabulut E
    Nucl Med Commun; 2008 Nov; 29(11):1002-5. PubMed ID: 18836380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
    Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A
    Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Background subtraction in technetium-99m-MAG3 renography.
    Taylor A; Thakore K; Folks R; Halkar R; Manatunga A
    J Nucl Med; 1997 Jan; 38(1):74-9. PubMed ID: 8998155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.
    Aktaş A; Aras M; Colak T; Gençoğlu A; Karakayali H
    Transplant Proc; 2006 Mar; 38(2):449-53. PubMed ID: 16549144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
    Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
    Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function.
    Taylor A; Ziffer JA; Eshima D
    Clin Nucl Med; 1990 Jun; 15(6):371-8. PubMed ID: 2141307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry of
    Arteaga MV; Caballero VM; Rengifo KM
    Appl Radiat Isot; 2018 Aug; 138():25-28. PubMed ID: 28781122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.